Impact of diabetes on haemoglobin levels in renal disease

Diabetologia

Volumn 50, Issue 1, 2007, Pages 26-31

  Ravanan, R ^a   Spiro, J R ^a   Mathieson, P W ^a   Smith, R M ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Anaemia; Diabetes; Diabetic nephropathy; Erythropoietin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FERRITIN; HEMOGLOBIN; PARATHYROID HORMONE;

ADULT; AMBULATORY MONITORING; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY DISEASE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NEPHROLOGIST; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ANEMIA; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 33845947549     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0514-y     Document Type: Article

References (38)

1. Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782-787
2. Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795-808
3. Frei U, Schober-Halstenberg HJ (2004) Renal replacement therapy in Germany, Annual Report 2003/2004. Quasi-Niere, Berlin
4. King H, Aubert RE, Herman WH (1998) Global burden of diabetes 1995-2025: prevalence, numerical estimates and projections. Diabetes Care 21:1414-1431
5. Chantrel F, Enache I, Bouiller M et al (1999) Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Tranplant 14:129-136
6. Keith DS, Nicolas DA, Gullion CM, Brown JB, Smith DH (2004) Longitudinal follow up and outcomes among a population with chronic kidney disease in a large managed care organisation. Arch Intern Med 164:659-663
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine. A new prediction equation. Modification of Diet in Renal Disease study group. Ann Intern Med 130:461-470
8. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Part 4 - Definition and classification of stages of chronic kidney disease. Am J Kidney Dis 39:S46-S75
9. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J (2002) Association of kidney function with anemia. The Third National Health And Examination Survey {1988-1994}. Arch Int Med 162:1401-1408
10. Thomas MC, MacIssac RJ, Tsalamandaris C, Power D, Jerums G (2003) Unrecognised anemia in patients with diabetes. Diabetes Care 26:1164-1169
11. Thomas MC, Mac Issac RJ, Tsalamandaris C et al (2004) Anemia in patients with type I diabetes. J Clin Endocrinol Metab 89:4359-4363
12. Craig KJ, Williams JD, Riley SG et al (2005) Anemia and diabetes in the absence of nephropathy. Diabetes Care 28:1118-1123
13. El-Achkar TM, Ohmitt SE, McCollough PA et al (2005) Higher prevalence of anemia with diabetes mellitus in moderate renal insufficiency: the Kidney Early Evaluation Program. Kidney Int 67:1483-1488
14. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ (2001) Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 24:495-499
15. Ishimura E, Nishizawa Y, Okuno S et al (1998) Diabetes mellitus increases the severity of anemia in non-dialysed patients with renal failure. J Nephrol 11:83-86
16. Erturk S, Ates K, Durman N, Karatan O, Erbay B, Ertug E (1996) Unresponsiveness to human recombinant erythropoietin in hemodialysis patients: possible implications of angiotensin converting enzyme inhibitors. Nephrol Dial Transplant 11:393-397
17. Kamper AL, Nielsen OJ (1990) Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy. Scand J Clin Lab Invest 50:611-618
18. Danielson B (1995) R-HuEPO hyporesponsiveness - who and why? Nephrol Dial Transplant 10(Suppl 2):69-73
19. Drueke TB (1995) R-HuEPO hyporesponsiveness - who and why? Nephrol Dial Transplant 10(Suppl 2):62-68
20. Rao DS, Shih MS, Mohini R (1991) Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328:171-175
21. Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ (1999) Erythropoietin depletion and anemia in diabetes mellitus. Diabet Med 16:813-819
22. Takaku F, Hirasima K, Okinaka S (1961) Effects of the bilateral section of splanchnic nerve on erythropoiesis. Nature 191:500-501
23. Spallone V, Maiello MR, Kurukulasuriya N et al (2004) Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric type 2 diabetic patients? Diabet Med 21:1174-1180
24. Bosman DR, Osborne CA, Marsden JT, Macdougall IC, Gardner WN, Watkins PJ (2002) Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet Med 19:65-69
25. Fioretto P, Mauer M, Brocco E et al (1996) Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia 39:1569-1576
26. Schmidt MI, Duncan BB, Sharrett RA (1999) Markers of inflammation and prediction of diabetes mellitus in adults: a cohort study. Lancet 353:1649-1652
27. Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286-1292
28. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the immune system? Diabetologia 41:1241-1248
29. Holmes GK (2002) Screening for coeliac disease in type 1 diabetes. Arch Dis Child 87:495-498
30. Parving H, Osterby R, Ritz E (2000) Diabetic nephropathy. In: Brenner BM, Levine S (eds) The kidney. Saunders, Philadelphia, PA, p 1731
31. The Diabetes Control and Complication Trial Research Group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial (DCCT). Kidney Int 47:1703-1720
32. Richards NT, Greaves I, Lee SJ, Howie AJ, Michael J (1992) Increased prevalence of renal biopsy findings other than diabetic glomerulopathy in type II diabetes mellitus. Nephrol Dial Transplant 7:397-399
33. Waldherr R, Ilkenhans C, Ritz E (1992) How frequent is glomerulonephritis in diabetes mellitus type II? Clin Nephrol 37:271-273
34. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH (2000) Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int 58:1719-1731
35. Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 32:112-119
36. Harnett JD, Kent GM, Foley RN, Parfrey PS (1995) Cardiac function and hematocrit level. Am J Kidney Dis 25:3-7
37. Keane WF, Brenner BM, de Zeeuw D et al (2003) The risk of developing end stage renal failure in patients with type 2 diabetes and nephropathy: The RENAAL study. Kidney Int 63:1499-1507
38. Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD (2004) Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int 66:1131-1138